Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	130
Overall Study	STARTED	CTP-543 8 mg BID	258
Overall Study	STARTED	CTP-543 12 mg BID	129
Overall Study	Efficacy Population	Placebo	127
Overall Study	Efficacy Population	CTP-543 8 mg BID	249
Overall Study	Efficacy Population	CTP-543 12 mg BID	127
Overall Study	Safety Population	Placebo	130
Overall Study	Safety Population	CTP-543 8 mg BID	256
Overall Study	Safety Population	CTP-543 12 mg BID	129
Overall Study	COMPLETED	Placebo	119
Overall Study	COMPLETED	CTP-543 8 mg BID	233
Overall Study	COMPLETED	CTP-543 12 mg BID	120
Overall Study	NOT COMPLETED	Placebo	11
Overall Study	NOT COMPLETED	CTP-543 8 mg BID	25
Overall Study	NOT COMPLETED	CTP-543 12 mg BID	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04797650/flow